Breast cancer is the most common malignant disease among women, with a lifetime risk of approximately 10%. Frequent and well-known locations of metastases are bone, liver, lung, skin and brain, but tumour repetition has been seen in almost any anatomic site. Orbital involvement is quite rare, or perhaps underestimated. Orbit metastases (OMs) represent 1-13% of all orbital cancers, and are difficult to discriminate with other differential diagnoses, such as a simple blepharitis, or orbital pseudotumor, up to more complex forms of cancer such as lymphoma. The prevalence of OMs is calculated to occur in 2-4.7% of primitive cancer patients. Typical manifestations of orbital metastases include overall regional inflammation, mass effect causing displacement or ocular globe proptosis, pain, bone infiltration, chemosis and eyelid swelling. Infiltration of soft tissue leads to ptosis, diplopia or enophthalmos. We report the case of a 70-year-old female patient who developed chronic inflammatory process of both orbital regions due to orbital metastases, without evidence of other systemic disease after 8 years from primary breast cancer diagnosis. The diagnostic pathway as well as the differential diagnosis are discussed.
Breast cancer is the most common malignant disease among women, with a lifetime risk of approximately 10%. Men seldom develop this malignancy and represent about 1% of all cases with diagnosis of breast cancer (1) . The biological properties and clinical features of breast cancer appear to be similar in both genders. Frequent and well-known locations of metastases are bone, liver, lung, skin and brain, but tumor manifestations have been seen in almost any anatomic site. Orbital involvement is quite rare, or perhaps underestimated (2) .
Orbit metastases (OMs) represent 1-13% of all orbital tumors and occur in 2-4.7% of patients with primitive cancer (2) . Metastases of breast cancer account for the majority of ocular and orbital metastases (3, 4) .
Typical manifestations of OMs include mass effect causing displacement or proptosis of the ocular globe, pain, inflammation, bone infiltration, (2) . Infiltration of soft tissue leads to ptosis, diplopia, or enophthalmos (5) . We report the case of a 70-year-old female patient with breast cancer who developed orbital metastases without evidence of systemic disease, after 8 years from primary diagnosis.
MATERIALS AND METHODS
A 70-year-old Caucasian female patient, who eight years previously had been diagnosed with breast cancer, sought treatment for a slowly developing massive periorbital inflammation with oedema, which was nonrespondent to corticosteroid therapy. The oncological yearly follow-up controls were negative for disease progression. Conjuctival and intra-palpebral lumps, bilateral eyelid chemosis, ptosis and pain were present on physical examination. The ophthalmologist noted no visual impairment.
Magnetic Resonance Imaging (MRI) of the orbit was performed with a 1.5 Tesla superconductive unit (Sonata, Siemens, Erlangen, Germany) using head and neck coil, and fat suppressed TSE Tl-weighted axial and coronal scans were performed after the I. V. administration of Gadolinium-DOTA (Dotarem, Guerbet, France). Therefore, surgical treatment was planned for diagnostic purposes and to treat the painful symptoms.
RESULTS
MRI revealed the presence of bilateral multiple orbital lesions without evidence of central nervous system involvement. T1 sequences with fat attenuation and after gadolinium contrast injection, demonstrated multiple hyperintense formations, mainly localized supero-laterally to each orbit ( Fig.  I) .
A subsequent open biopsy was scheduled. Through a bilateral lower lid subciliar incision, part of periorbital fat was removed and multiple random biopsies of the tissue were sent to Pathology. A conjunctival lesion of the left eye was removed for therapeutic and diagnostic purposes. Upper blepharoplasty was performed removing bilateral eyelid lesions, which in the right eye had a macroscopic cartilage-like appearance.
The specimen was received fresh in surgical pathology. A portion was embedded in O.c.T. compound and a routine frozen section was prepared for hematoxylin-eosin staining. The remaining specimen was formalin fixed and paraffin-embedded (FFPE). Fixed-tissue sections were stained with hematoxylin-eosin for light microscopy. Immunohistochemistry for estrogen receptor (clone IDS, Dako, Denmark) and for cytokeratin (clone AEl/AE3, Dako, Denmark) on FFPE tissue sections was also performed using an automated immunostainer (Dako, Denmark). Extemporaneous histological examination revealed metastatic breast cancer.
The diagnosis of orbital metastases from primary breast carcinoma was confirmed by definitive histological examination. Histologically, sections of both the frozen tissue and formalin-fixed paraffinembedded tissue showed a dermal infiltration of atypical, discohesive small cells with uniform round nuclei, indistinct nucleoli and a thin rim of cytoplasm with occasional intracytoplasmic lumens (Fig. 2) .
Occasionally an "Indian-file" pattern of infiltration was also observed.
Immunohistochemical stains were performed, and the infiltrating cells were found to be positive for cytokeratin and estrogen receptor (Fig. 3) . The morphology and the immunophenotype of tumor cells were consistent with an orbital metastasis of lobular carcinoma of the breast.
The postoperative period was without complications and with subtotal disappearance ofthe eyelid chemosis and pain. The patient was referred to the oncology department for further treatment, refused the care.
DISCUSSION
We present a case of OMs in a patient affected by breast cancer whose clinical presentation was mimicking a chronic inflammatory disease. This case is peculiar because OMs were bilateral, presenting a long time after the primary cancer, and only histology led to a diagnosis.
Some studies (6, 7) have indicated that OMs are more common in the left orbit, but it is still not ascertained whether metastatic disease is more common on one side or the other. Many studies stress a right eye dominance or bilateral straight forms (8) . Different distribution of OMs in orbit quadrants has been reported: 39% lateral quadrants, 32% medial quadrants and 20% inferior lateral quadrants (3, 8) .
In clinical practice, orbital metastases seem to be rare, although several studies suggest orbital involvement in 10-37% of patients with metastatic breast cancer (9) (10) (11) (12) . In 12-31% of cases, orbits may be the first location of a neoplastic form or its dissemination (1O, [13] [14] [15] .
Risk factors are dissemination of the disease in multiple organs and, in particular, pulmonary or cerebral metastases (16) . Eye symptoms depend by OM location and may be characterized by vision disorders in cases with choroid involvement and glaucoma, when anterior segments are involved. Diplopia may be the first manifestation of OMs, while large tumors may cause exophthalmos, and sclerotic ones (scirrhous carcinomas) may cause enophthalmos (5) . Orbital and periorbital pain and diplopia (or other ocular movement disorders) represent other referred symptoms.
For the above-mentioned reasons, radiologic investigations such as CT and/or MRI are mandatory (12) . These techniques seem to have the same accuracy but the development of special MRI sequences, such as fat suppressed T I, lead to a preference for MRI in most cases (17, 18) . Additional advantage is no radiation to the eyes. On MRI, metastatic disease is usually hypointense to fat on Tl-weighted images and hyperintense to fat on T2 -weighted images. This appearance may help to differentiate it from an orbital pseudotumor, which is usually isointense to fat on T2-weighted images. When hyperintense lesions are seen on T I weighted images, a highly vascular metastasis (e.g. thyroid, renal, melanoma) should be suspected (19) . For the patient presented in this case review MRI showed the presence of multiple hyperintense lesions, at post contrast Tl weight fat suppression acquisition.
Biopsy is indicated for diagnostic purposes in doubtful situations, and it can be performed by needle aspiration or open surgery. Needle aspiration is widely recognized as an excellent technique for reliable diagnostic results (8, 19, 20) , although some studies have reported a risk of cancer cell dissemination (20, 21) . Loss of vision, diplopia and bleeding are other potential hazards of retro bulbar biopsy.
The goals of treatment in case of orbital metastases are quality oflife improvement and visual acuity preservation or restoring, thus representing a palliative therapy. Subsequent treatment includes radiation, chemotherapy, hormone therapy, surgery or a combination of these. Radiotherapy appears to be the best treatment, giving satisfactory control in cancer growth as well as visual acuity preservation and restoring (22) , with proptosis improvement and low incidence of keratitis. The radiation dose varies from 32 to 50 Gy depending on the location of the metastases.
Chemotherapy is useful in hormone-sensitive disease, thus cancer markers should be obtained by tissue samples (22, 23) .
Surgical treatment offers no advantage over the others and is reserved only for patients with evident abnormalities of ocular motility or marked exophthalmos (8, 10, 24) . Surgery is indicated as palliative therapy in patients with severe pain orland severe diplopia. For lesions involving sinuses and skull base, surgery can be performed in endoscopy. After surgery cold therapy is recommended, it decreases swallowing and pain.
In conclusion, after this case report, surgery confirmed its role as part of the treatment of breast cancer OMs. However, it is reserved for diagnostic purposes or as palliative therapy in patients with severe symptoms. OM diagnosis is difficult due to symptoms overlapping with other benign disease, such as pseudotumor, and disease rarity.
